-comp289331.png)
Glac Biotech Co, Ltd.
About
Company description
Glac Biotech is a leading and innovative contract manufacturing company of probiotics and postbiotics in Taiwan. We specialize in clinically-tested, patented, and efficacy probiotic and postbiotic ingredients, and customizable nutraceutical products with a focus on food and beverage, dietary supplement, and healthcare markets.
Since established in 2008, Glac has been dedicated to the field of functional probiotics and postbiotics for decades. We have developed over 1,000 probiotic strains, efficacy verification, and have established an independent microbial strain database.
Our functional probiotics cover Gastrointestinal Health, Immunity Support, Urogenital Health, Oral Care, Sleep Aid, Liver & Uric acid Management, Glucose Control, Weight Management, and more with our world-exclusive PRONULIFE.
Quick facts
Sales markets | Asia; Australia; Central/South America; Eastern Europe; North America; Western Europe |
---|---|
Primary business activity | Contract Manufacturer |
Affiliated categories: | Food Supplements / Nutraceuticals |Postbiotics |Prebiotics More |
Upcoming events
Vitafoods Europe 2024
14 - 16 May 2024 - Geneva, Switzerland Visit us at stand N237 Book a meeting See our Exhibitor Profile See full Exhibitor ListRecently at
Fi Europe
28 - 30 Nov 2023 Frankfurt, Germany We were at stand 3.0H65 See our Exhibitor Profile See full Exhibitor ListVitafoods Asia 2023
20 - 22 Sept 2023 Bangkok, Thailand We were at stand F01 See our Exhibitor Profile See full Exhibitor ListVitafoods Europe Online and In-Person
1 - 12 May 2023 - Online We were at stand J267 See our Exhibitor Profile See full Exhibitor ListNews about Glac Biotech Co, Ltd.

17 Oct 2023
Asia Number One! Glac Totipro®Postbiotics PE0401 Named WINNER at NutraIngredients Asia Awards 2023!
New Proud Achievement in the World of Postbiotics! Totipro®Postbiotics PE0401 has earned recognition as the FIRST in the world to excel in the "Ingredient: Microbiome Modulation" category, specifically for gastrointestinal function enhancement!
Read more26 Apr 2023
Glac Biotech Launches Clinically Tested Postbiotic Ingredients for Oral and Intestinal Health
Postbiotics, which consist of inanimate microorganisms and their metabolites, have become a validated class of ingredients supported by a large amount of science evidence showing similar outcomes to probiotics without the challenges of thermo-limitation. Glac Biotech, a contract manufacturer at the forefront of postbiotics in Taiwan, has been able to launch clinically proven ingredients:Totipro® PE0301(Oral Health) and Totipro® PE0401(Inte...
Read more24 Apr 2023
Glac B. animalis subsp. Lactis CP-9 has been selected as a finalist in the NutraIngredient Awards Europe 2023
Glac are thrilled to announce that our human breast milk-derived probiotic Bifidobacterium animalis subsp. Lactis CP-9 has been selected as a finalist in the NutraIngredient Awards Europe 2023: Weight Management category!
Read more